Compare OVID & GGZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OVID | GGZ |
|---|---|---|
| Founded | 2014 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 117.5M | 112.4M |
| IPO Year | 2017 | N/A |
| Metric | OVID | GGZ |
|---|---|---|
| Price | $1.61 | $15.41 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $3.50 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 12.8K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 5.39% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.75 |
| Revenue | ★ $6,610,000.00 | N/A |
| Revenue This Year | $1,077.56 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $6.79 |
| Revenue Growth | ★ 945.89 | N/A |
| 52 Week Low | $0.24 | $9.43 |
| 52 Week High | $2.01 | $12.50 |
| Indicator | OVID | GGZ |
|---|---|---|
| Relative Strength Index (RSI) | 48.35 | 72.37 |
| Support Level | $1.57 | $14.94 |
| Resistance Level | $1.65 | $15.24 |
| Average True Range (ATR) | 0.10 | 0.17 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 13.33 | 100.00 |
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
The Gabelli Global Small and Mid Cap Value Trust is a diversified closed-ended management investment company whose investment objective is long-term capital growth. It invests in equity securities such as common stock and preferred stock of companies.